FDA Import Refusal AEK-8423822-6/21/1 — Cipla Ltd.
The FDA refused shipment AEK-8423822-6/21/1 from Cipla Ltd. (India) on Nov 22, 2021. The refused product falls under Drugs and Biologics — BUDESONIDE (ANTI-ASTHMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 22, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61ECY04 BUDESONIDE (ANTI-ASTHMATIC)
- Charges
- 75